Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
Lipton, Richard B., Munjal, Sagar, Brand‐Schieber, Elimor, Tepper, Stewart J., Dodick, David W.Language:
english
Journal:
Headache: The Journal of Head and Face Pain
DOI:
10.1111/head.13663
Date:
October, 2019
File:
PDF, 216 KB
english, 2019